#IOVA
Top trade: 732 Nov 20 calls, $18K, 5x open interest.
70% of the $1.3M in #$IOVA options premium on Nov 13 went to puts.
Volume that far above open interest points to new positions being opened.

Full story at the link.
#optionsflow #stocks #optionstrading #stockmarket
Week in Review: IOVA Options Flow and Dark Pools, Nov 9-13
A large, unusual options bet just hit IOVA. When traders open new positions this size, it can signal they expect a big move. Here's what the flow shows.
globaltradersacademy.com
November 14, 2026 at 9:17 PM
#$IOVA: The dark pool ratio Nov 13 was 0.7x normal and the 5-day trend is fading.
Off-exchange shares (share of volume): Nov 13 4,557,124 (39.0%).

Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.

Full story at the link.
#darkpool #stocks #stockmarket
Iovance Biotherapeutics (IOVA) Stock Week Ahead: Options Flow Braces for an 8.8% Swing by Friday
Iovance Biotherapeutics (IOVA) week ahead: the options market's expected move, where the options money sits, last week's dark pools and the levels that matter (Nov 14).
globaltradersacademy.com
November 14, 2026 at 3:17 PM
November 11, 2026 at 8:00 AM
🚨 $IOVA
Roche Corleen M. (Chief Financial Officer) reported special transactions (Non-P/S).
SEC Filing: IOVA
Click to view the official SEC document.
www.sec.gov
November 10, 2026 at 10:05 PM
Iovance Biotherapeutics ($IOVA) – New 4.8% holder

• Holder: State Street
• Stake: 0 → 4.8% (about $175M)
• About 13G: a passive investor, not seeking to influence the company
• Filed: Nov 10 · Schedule 13G

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#Investing #Stocks
State Street Corp: 4.8% of Iovance Biotherapeutics ($IOVA)
Schedule 13G filed Nov 10. Who filed, the stake, and how it changed.
elixstocks.com
November 11, 2026 at 6:58 PM
Now playing on DFM: Money On My Mind by IOVA! Tune in now: https://a12.asurahosting.com/public/dfm
November 8, 2026 at 6:47 AM
$IOVA: Iovance reported Q3 product revenue of $121.5M, with U.S. Amtagvi about $102M, gross margin near 60% and a net loss of $22.3M. Not investment advice.

https://www.merlintrader.com/iovance-biotherapeutics-stock-hub/
November 8, 2026 at 12:25 PM
Iovance: Record Q3 product revenue ~$121.5M (+80%), guidance $410–420M on track; cash ~$382M; POSITILITY enrollment starts Nov.

#$IOVA FAQ + PDF: www.merlintrader.com/iovance-biot...
IOVA Stock: Iovance News, Amtagvi & Clinical Data
Iovance stock news and analysis: Amtagvi sales, lifileucel clinical updates, the revenue outlook, cash and key commercial and clinical risks for IOVA holders.
www.merlintrader.com
November 5, 2026 at 5:51 PM
Solar-Is - Книга Иова

https://youtu.be/Nw5mwWtuteM?list=RDNw5mwWtuteM...

https://artblack.name/2026/11/06/solar-is-kniga-iova/
November 6, 2026 at 3:24 PM
🚨 $IOVA
On November 5, 2026, Iovance Biotherapeutics, Inc. updated its corporate presentation that it uses for presentations at healthcare conferences and to analysts, current stockholders, and others.
SEC Filing: IOVA
Click to view the official SEC document.
www.sec.gov
November 5, 2026 at 10:12 PM
Latest company news, Nov 5: $IOVA Q3 product revenue $121.5M, +80% y/y, net loss $22.3M vs $91.3M, ~$382M cash, 2026 guidance $410-420M reaffirmed. Runway into 2029.
https://www.merlintrader.com/iovance-biotherapeutics-stock-hub/
November 6, 2026 at 5:02 PM
🚨 $IOVA
On November 5, 2026, Iovance Biotherapeutics, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026, and an update on recent developments.
SEC Filing: IOVA
Click to view the official SEC document.
www.sec.gov
November 5, 2026 at 12:09 PM
🇺🇸🇺🇸🇺🇸Vítězství demokratů v Kansasu a Iova značí, že demokrati vyhráli Senát🇺🇸🇺🇸🇺🇸
November 4, 2026 at 4:42 AM
#$IOVA — Q3 2026 record revenue of $121.5M, up 80% YoY

- U.S. Amtagvi revenue ~$102M; 1,000+ patients commercially treated
- Gross margin hits all-time high ~60%; R&D spend down 34% YoY
- Lung cancer trial: 24.6% ORR overall, 59.1% in biomarker-selected patients
November 5, 2026 at 12:23 PM
Biggest moves over the 5 sessions to Nov 2, stocks over $300M.

$GDYN +59.0%

$REPL +56.3%

$ULCC +51.3%

$DRUG -48.7%

$IOVA -41.8%

$OFRM -40.7%
November 3, 2026 at 12:15 PM
$IOVA down 7.3% to $7.87 on 5,610,056 shares versus an $8.48 prior close, Tapeboard chart is up, scanner is tracking the move. What level are you w… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=iova-bk-dn-watch&utm_term=scanner&s=IOVA
November 2, 2026 at 3:34 PM
Oct 29: IOV-LUN-202 ORR 24.6% in 69 NSCLC patients; sBLA planned 2027.

#$IOVA weekly close $8.48 (-39.8% w/w), below SMA50 $11.37 / above SMA200 $5.84, RSI 30.4.

IOVA Stock Hub: Iovance News, Amtagvi and Clinical Data
www.merlintrader.com/iovance-biot...
IOVA Stock: Iovance News, Amtagvi & Clinical Data
Iovance stock news and analysis: Amtagvi sales, lifileucel clinical updates, the revenue outlook, cash and key commercial and clinical risks for IOVA holders.
www.merlintrader.com
November 2, 2026 at 9:47 AM
$SLS breakout moving down 8.6% to 8.85 from 9.68 on 12,436,380 shares. SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cance… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=sls-bk-dn-scanner&utm_term=scanner&s=SLS
November 2, 2026 at 8:20 PM
Biggest movers this week ($2B+, with options) - up: $SGRY +47.4%, $ADT +42.9%, $GKOS +32.8%. Down: $XP -53.0%, $IOVA -39.8%, $BBD -37.3%.
Scan for them yourself, free: glsequity.com/scanners
October 31, 2026 at 12:55 PM
$IOVA lung cancer TIL data consistent with prior results, stock down 10.8% to $8.53 on 15,658,400 shares. Breakout down session, Tapeboard scanne… https://tapeboard.com/go/bsky/research/IOVA?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=iova-bk-dn-scanner&utm_term=research
October 30, 2026 at 4:02 PM
$IOVA lung cancer TIL data consistent with prior results, stock down 10.8% to $8.53 on 15,658,400 shares. Breakout down session, Tapeboard scanne… https://tapeboard.com/go/bsky/research/IOVA?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=iova-bk-dn-scanner&utm_term=research
October 30, 2026 at 4:02 PM
$IOVA down 12.3% this session at $8.38, Tapeboard flagged at $10.31 and it's given most of that back on 6.39M shares. Lifileucel lung cancer data… https://tapeboard.com/go/bsky/research/IOVA?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=iova-bk-dn-scanner&utm_term=research
October 30, 2026 at 2:00 PM